Operating Lease, Right-of-Use Asset of LIPELLA PHARMACEUTICALS INC. from 31 Dec 2021 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
LIPELLA PHARMACEUTICALS INC. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2021 to 30 Sep 2025.
  • LIPELLA PHARMACEUTICALS INC. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $262,823, a 278% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

LIPELLA PHARMACEUTICALS INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $262,823 +$193,268 +278% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 $274,539 +$182,561 +198% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $23,572 -$90,466 -79% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $46,754 -$88,390 -65% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 $69,555 -$86,851 -56% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $91,978 -$30,568 -25% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $114,038 -$22,756 -17% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $135,144 -$15,677 -10% 31 Dec 2023 10-K 28 Mar 2025 2024 FY
Q3 2023 $156,406 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $122,546 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $136,794 31 Mar 2023 10-Q 12 May 2023 2023 Q1
Q4 2022 $150,821 -$53,979 -26% 31 Dec 2022 10-K 27 Feb 2024 2023 FY
Q4 2021 $204,800 31 Dec 2021 10-K 31 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.